Articles by Sonja Puhl
Ten Tips for Lateral Flow Assay Development
In this guide, we will provide you with valuable insights and practical tips to streamline your lateral flow assay development process and enhance the performance of your assays. Whether you're a novice researcher or an experienced assay developer, these tips will help you navigate the complexities of lateral flow assay development and achieve reliable results. Read more
mRNA Vaccine for Melanoma: What Moderna and Merck Have Just Achieved
Moderna and Merck have reported positive Phase 3 results for a personalized mRNA-based cancer therapy in high-risk melanoma.[1] This is an important clinical milestone, but it is not yet a regulatory approval: the companies still need to present detailed data and submit the treatment for review by health authorities.[1] Read more
Publications by Sonja Puhl
Oezdemir, Gaisa, Lindemann-Docter, Gostek, Weiskirchen, Ahrens, Schwamborn, Stephan, Pfister, Heidenreich, Knuechel, Henkel: "Proteomic tissue profiling for the improvement of grading of noninvasive papillary urothelial neoplasia." in: Clinical biochemistry, Vol. 45, Issue 1-2, pp. 7-11, (2012) (PubMed).
Mijnes, Veeck, Gaisa, Burghardt, de Ruijter, Gostek, Dahl, Pfister, Schmid, Knüchel, Rose: "Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: RBBP8/CtIP is almost exclusively methylated in bladder cancer." in: Clinical epigenetics, Vol. 10, pp. 15, (2019) (PubMed).
Vasko, Hoffmann, Gostek, Schettgen, Quinete, Preisinger, Kraus, Ziegler: "Telomerase gene expression bioassays indicate metabolic activation of genotoxic lower chlorinated polychlorinated biphenyls." in: Scientific reports, Vol. 8, Issue 1, pp. 16903, (2019) (PubMed).